China Digest: New Vision, Coherent Biopharma snap funding
Shunwei Capital-backed New Vision has raised $28.7 million in a Series D round, while Coherent Biopharma has secured $100 million in Series B and B+ rounds.
Hefei Industry Investment Holding International Holdings Agricultural Bank Jiangsu Hengrui Pharmaceuticals Shanghai Alliance Investment Shunwei Capital Backed New Vision
Source: dealstreetasia.com